Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Vida

Translating data to create a meaningful story

Embracing data to create numerous possibilities

- PMLiVE

May’s Brexit plan cautiously welcomed by biopharma sector

The white paper says the UK should adhere to EMA regulations post-Brexit

- PMLiVE

Daily Brief: Novartis exits anti-infectives drive, Hancock takes over from Hunt and Trump attacks ‘soft Brexit’ plan

The latest from pharma, biotech and healthcare

Can new data aggregators shift the balance of power away from pharma?

Making data a core competence

- PMLiVE

ABPI blames doctor payment disclosure dip on GDPR

Figures drop to 49% from almost 65% last year

- PMLiVE

Daily Brief: Dementia Fund hits $350m mark, hard Brexit could cost £100bn in trade and troublesome results for Pfizer’s Ibrance

The latest news from across pharma, biotech and healthcare

- PMLiVE

Irish survey lists pharma firms’ top five Brexit concerns

Talent access restrictions topped the list

- PMLiVE

The Directory and digital round-up

SOPHiA Genetics acquires IBS, Kyomed becomes KYomed INNOV and launches ePRO, Medtronic unveil diabetes app

Medical information in precision medicine

Global Medical Information Leader James Oughton reveals the top trends in medical information and precision medicine.

Blue Latitude Health

- PMLiVE

NHS could save £7bn with greater diagnostics use

Report suggests IVD tests could be key to big savings

- PMLiVE

May earmarks £20bn for the NHS – but experts say it’s not enough

But claims of a “Brexit dividend” are rubbished

- PMLiVE

British Business Bank sets up £2.5bn fund for ‘unicorn’ firms

UK government says the private sector will bring in another £5bn in investments

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links